期刊文献+

葡萄糖激酶Y214C活性突变的理论研究 被引量:2

Theoretical Study of Abrupt Change of Activity via Y214C Mutation of Glucokinase
下载PDF
导出
摘要 葡萄糖激酶(GK)催化葡萄糖转变为6-磷酸葡萄糖,这是糖代谢的第一步.正因为如此,GK活性异常在糖代谢紊乱的发生发展中起着重要作用.对青年型早发糖尿病(MODY2)和高胰岛素性低血糖症(PHHI)的深入研究证实GK活性改变与糖尿病的发生有关.为了研究GK活性改变的机理,利用分子动力学模拟和隐性溶剂的自由能计算对GK的单点突变Y214C(Tyr214→Cys)进行了理论研究.通过GK的Cα原子均方根浮动变化(RMSF)和动态相关性矩阵(DCCM)分析发现,Y214C突变导致处于活化状态的GK的构象更加稳定;通过包结自由能分析发现,Y214C突变可增加GK对葡萄糖的包结亲合性.相关研究结果有助于从原子水平理解Y214C活性突变的机制,并为糖尿病的治疗提供一定的理论参考. Glucokinase(GK) is a glycolic enzyme that catalyzes the phosphorylation of glucose to glucose-6-phosphate,the first step of glycolysis.This is why variation in activity of GK plays an important role in abnormal glycemia.Actually,numerous researches about maturity-onset diabetes of the young 2(MODY 2) and persistent hyperinsulinemic hypoglycemia of infancy(PHHI) have confirmed that varying activity of GK is related to occurrence of diabetes.Therefore,explicit molecular dynamics simulations and implicit solvent binding free-energy calculations were carried out to investigate the activation mechanism of GK point mutation Y214C(Tyr214 →Cys).Based on root mean square fluctuation(RMSF) and dynamic cross-correlation matrices(DCCM) conformation analysis,it was found that GK Y214C mutation resulted in a more stable active conformation of GK.Analysis of binding free-energy demonstrated that the GK Y214C point mutation resulted in increased binding affinity of GK with glucose.Relevant findings are beneficial to understanding the activation mechanism of GK Y214C mutation at atomic level and contributing to treatment of diabetes.
作者 姚雪霞
出处 《化学研究》 CAS 2010年第6期71-76,共6页 Chemical Research
关键词 葡萄糖激酶 活性 突变 理论研究 glucokinase activity abrupt change theoretical study
  • 相关文献

参考文献24

  • 1Wilson J E. Hexokinases [J]. Rev Physiol Biochem Pharmacol, 1995, 126:65-198.
  • 2Ferre T, Riu E, Bosch F, et al. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver [J]. FASEB J, 1996, 10.1213-1218.
  • 3Vionnet N, Stoffel M, Takeda J, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus [J].Nature, 1992, 356:721-722.
  • 4Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus[J]. N Engl J Med, 1993, 328.697- 702.
  • 5Glaser B, Kesavan P, Heyman M, et al. Brief report: familial hyperinsulinism caused by an activating glucokinase mutation [J]. N Engl J Med, 1998, 338:226-230.
  • 6Christesen H B T, Jacobsen B B, Odili S, et al. The second activating glucokinase mutation (A456V) : implications for glucose homeostasis and diabetes therapy [J]. Diabetes, 2002, 51:1240-1246.
  • 7Kamata K, Mitsuya M, Nishimura T, et al. Structural basis for allosteric regulation of themonomeric allosterie enzyme human glucokinase [J].Structure, 2004, 12:429-438.
  • 8Grimsby J, Sarabu R, Corbett W L, et al. Allosteric activators of glucokinase. potential role in diabetes therapy [J]. Science, 2003, 301:370-373.
  • 9Matschinsky F M. Assessing the potential of glucokinase activators in diabetes therapy [J]. Nat Rev Drug Discov, 2009, 8:399-416.
  • 10Zhang J, Li C J, Chen K X, et al. Conformational transition pathway in the allosteric process of human glucokinase [J]. Proc Natl Acad Sci USA, 2006, 103 : 13368- 13373.

同被引文献46

  • 1肖梅芳,张学梅,白香,谭焕然.不同糖尿病模型小鼠糖原代谢变化的研究[J].中国临床药理学与治疗学,2005,10(6):613-616. 被引量:22
  • 2欧阳礼枝,陆付耳,刘文军,高志强,徐丽君.小檗碱对胰岛素抵抗大鼠肝脏葡萄糖激酶及其调节蛋白的影响[J].世界华人消化杂志,2007,15(8):885-889. 被引量:17
  • 3FERRE T, RIU E, BOSCH F, et al. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver[J]. FASEBJ, 1996, 10(10):1213-1218.
  • 4NOGUEIRA F N, SANTOS M F, NICOLAU J. Influence of streptozotocin-induced diabetes on hexokinase activity of rat salivary glands [J]. J Physiol Biochem, 2005, 61(3):421-428.
  • 5KAMATA K, MITSUYA M, NISHIMURA T, et al. Structural basis for allosteric regulation of themonomeric allosteric enzyme human glucokinase [J]. Structure, 2004, 12 (3) : 429- 438.
  • 6VIONNET N, STOFFEL M, TAKEDA J, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insu- lin-dependent diabetes mellitus [J]. Nature, 1992, 356(6371) : 721-722.
  • 7GRIMSBY J, SARABU R, CORBETT W L, et al. Allosteric activators of glucokinase: potential role in diabetes therapy [J]. Science, 2003, 301(5631): 370-373.
  • 8FUTAMURA M, HOSAKA H, KADOTANI A, et al. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism [J]. J Biol Chem, 2006, 281(49) : 37668 -37674.
  • 9IINO T, TSUKAHARA D, KAMATA K, et al. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N thiazolyl benzamides as novel allosteric glucokinase activators [J]. Bioorg Med Chem, 2009, 17(7): 2733-2743.
  • 10NISHIMURA T, IINO T, MITSUYA M, et al. Identification of novel and potent 2 amino benzamide derivatives as allosteric glucokinase activators [J]. J Bioorg Med Chem Lett, 2009, 19(5): 1357-1360.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部